Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × COVID-19 × remdesivir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Follicular 1 COVID-19 1

Interventions

sotrovimab 1 remdesivir 1 ciclesonide 1 Standard of Care 1 Niclosamide 1 COVID-19 Serotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Klinikum Bremen-Mitte, gGmbH

Phase 2/3 Withdrawn

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡